2RGP
Structure of EGFR in complex with hydrazone, a potent dual inhibitor
2RGP の概要
| エントリーDOI | 10.2210/pdb2rgp/pdb |
| 分子名称 | Epidermal growth factor receptor, PHOSPHATE ION, N-[1-(3-fluorobenzyl)-1H-indazol-5-yl]-5-[(piperidin-1-ylamino)methyl]pyrimidine-4,6-diamine, ... (4 entities in total) |
| 機能のキーワード | kinase domain, alternative splicing, anti-oncogene, atp-binding, cell cycle, disease mutation, glycoprotein, membrane, nucleotide-binding, phosphoprotein, polymorphism, receptor, secreted, transferase, transmembrane, tyrosine-protein kinase, ubl conjugation |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P00533 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 36707.27 |
| 構造登録者 | |
| 主引用文献 | Xu, G.,Abad, M.C.,Connolly, P.J.,Neeper, M.P.,Struble, G.T.,Springer, B.A.,Emanuel, S.L.,Pandey, N.,Gruninger, R.H.,Adams, M.,Moreno-Mazza, S.,Fuentes-Pesquera, A.R.,Middleton, S.A. 4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors. Bioorg.Med.Chem.Lett., 18:4615-4619, 2008 Cited by PubMed Abstract: Members of a novel class of 4-amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones were identified as potent dual ErbB-2/EGFR kinase inhibitors using concept-guided design approach. These compounds inhibited the growth of ErbB-2 over-expressing human tumor cell lines (BT474, N87, and SK-BR-3) in vitro. Compound 15 emerged as a key lead and showed significant ability to inhibit growth factor-induced receptor phosphorylation in SK-BR-3 cells (IC(50)=54 nM) and cellular proliferation in vitro (IC(50)=14, 58, and 58 nM for BT474, N87, and SK-BR-3 respectively). The X-ray co-crystal structure of EGFR with a close analog (17) was determined and validated our design rationale. PubMed: 18653333DOI: 10.1016/j.bmcl.2008.07.020 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






